Rajasthan govt halts distribution of all 19 medicines supplied by Kayson Pharma

Rajasthan government has suspended Drug Controller Rajaram Sharma and halted the distribution of all 19 medicines supplied by Kayson Pharma.

The action was taken after two children died and several fell ill, allegedly due to the consumption of cough syrups distributed under the Chief Minister’s Free Medicine Scheme.

The Health Department cited quality control failures. The state has also banned the supply of cough syrups containing dextromethorphan from all manufacturers after several batches failed quality tests.

According to Rajasthan Medical Services Corporation Limited, 10 thousand 119 samples of Kayson Pharma’s medicines have been tested since 2012, with 42 found to be substandard. Chief Minister Bhajan Lal Sharma has ordered a detailed investigation into the issue.

An expert committee is being formed to examine how the medicines passed existing checks and what failures occurred in the quality assurance process.

Related Posts

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

The Team Meticulously averted the Risk of Thrombosis, Husband was Donor Delhi/NCR : Doctors at Yashoda Medicity have successfully performed a high-risk kidney transplant in a 28-year-old woman with Antiphospholipid…

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

Avacta, a UK-based clinical stage biotech, is differentiated clinical-stage oncology specialist, increasingly defined by continuing progress with its second-generation pre|CISION tumour-activated Peptide Drug Conjugate (PDC) platform. The lead Gen Two…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

Puresta launches EVERQ, AI-powered skin-health platform

Puresta launches EVERQ, AI-powered skin-health platform

Stem cell therapy for autism only in approved clinical trials: Centre

Stem cell therapy for autism only in approved clinical trials: Centre